Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSULET CORPORATION

(PODD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insulet : Significant Insider Selling in Shares of Insulet (PODD) Continues

08/19/2021 | 10:20pm EDT


© MT Newswires 2021
All news about INSULET CORPORATION
10/18INSULET : Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and ..
PU
10/18INSULET CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financ..
AQ
10/18INSULET : Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and ..
BU
10/18Insulet Announces Management Changes
CI
10/04INSIDER SELL : Insulet
MT
10/04INSULET CORP : Other Events (form 8-K)
AQ
09/30INSULET : Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycem..
BU
09/30Insulet’S Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Gly..
CI
09/29INSULET : to Announce Third Quarter 2021 Financial Results on November 4, 2021
BU
08/26INSULET : to Present at Upcoming Investor Conferences
BU
More news
Analyst Recommendations on INSULET CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 084 M - -
Net income 2021 21,3 M - -
Net Debt 2021 258 M - -
P/E ratio 2021 927x
Yield 2021 -
Capitalization 20 893 M 20 893 M -
EV / Sales 2021 19,5x
EV / Sales 2022 16,1x
Nbr of Employees 1 900
Free-Float 99,6%
Chart INSULET CORPORATION
Duration : Period :
Insulet Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSULET CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 303,35 $
Average target price 286,68 $
Spread / Average Target -5,49%
EPS Revisions
Managers and Directors
Shacey Petrovic President, Chief Executive Officer & Director
Wayde Dwight McMillan Chief Financial Officer, Treasurer & Executive VP
Timothy J. Scannell Independent Chairman
Trang Ly Senior Vice President & Medical Director
Charles Alpuche Chief Operations Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
INSULET CORPORATION16.84%20 893
ABBOTT LABORATORIES14.21%221 691
MEDTRONIC PLC3.85%163 718
BECTON, DICKINSON AND COMPANY-1.50%70 784
HOYA CORPORATION19.13%55 133
DEXCOM, INC.53.66%54 963